David Geffen School of Medicine, UCLA

• Lisa Hyde-Barrett

Background

The David Geffen School of Medicine is part of the UCLA Health System. As part of the UCLA Health System, each patient receives the highest quality of care possible within its network of cancer care hospitals that includes the Jonsson Comprehensive Cancer Center at UCLA, which is designated as a Comprehensive Cancer Center by the National Cancer Institute. The Jonsson Comprehensive Cancer Center is one of the nation’s leading cancer research and treatment centers, receiving an estimated $40.1 million dollars each year to conduct oncological research from the National Cancer Institute.

Mesothelioma Treatments

The David Geffen School of Medicine along with the Jonsson Comprehensive Cancer Center is situated to provide the latest research developments to provide improved cancer treatment options. The integrated research environment provides collaboration of laboratory scientists and physicians within clinical, translational, and prevention research studies.

With regard to lung cancers, Jonsson Comprehensive Cancer Center was awarded a SPORE grant (Specialized Programs of Research Excellence) through the National Cancer Institute to provide an integrated research structure that allows cancer centers to bring together top scientists from multidisciplinary fields to address specific lung cancer questions and to bring cutting edge research directly from the laboratory to the bedside.

Radiation oncology, surgical oncology, clinical trials, chemotherapy, palliative care, state of the art diagnostics and imaging services, pathology, genetic counseling, hormone therapy, biological therapy, complementary and alternative medicine, nutrition and physical therapy, and comprehensive and preventive care are all options in the UCLA Health System cancer treatment programs.

Source: http://medschool.ucla.edu/